Vanda Pharmaceuticals Sues U.S. Government Over Alleged Misuse of Confidential Drug Data
02 Maio 2023 - 2:43PM
Dow Jones News
By Sabela Ojea
Vanda Pharmaceuticals Inc. said Tuesday that it has sued the
U.S. government for allegedly sharing trade secrets and
confidential information related to two of its medications.
The biopharmaceutical company alleged the U.S. Food and Drug
Administration improperly provided confidential details from its
sleep-wake disorder drug Hertlioz and schizophrenia treatment
Fanapt to generic drug manufacturers as it reviewed the company's
new drug applications.
The lawsuit seeks an award of economic damages, the company
said, noting that it was filed in the U.S. Court of Federal
Claims.
Fanapt and Tasimelteon were approved by the FDA in 2009 and
2014, respectively.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
May 02, 2023 13:28 ET (17:28 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Vanda Pharmaceuticals (NASDAQ:VNDA)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
